- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05517967
An Examination of Brown Adipose Tissue and Energy Expenditure in Infants (Born2Burn)
September 25, 2023 updated by: Emily W. Flanagan, MS, PhD, Pennington Biomedical Research Center
Excess fetal adipose tissue growth during intrauterine development increases future obesity risk.
Development of brown adipose tissue, a highly thermogenic organ in utero, may affect postnatal energy expenditure, thus influencing obesity risk.
This research study is designed to understand the developmental origins of energy balance by examining maternal and neonatal factors that influence neonatal brown adipose tissue and to quantify its physiological relevance to energy expenditure in human neonates.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The developmental origins of obesity begin in utero with growth and differentiation of adipose tissue.
Fetal white adipose tissue accretion is highly variable and dependent on the maternal intrauterine environment.
Unlike white adipose tissue, brown adipose tissue has a high capacity for thermogenesis.
Brown adipose tissue is present at birth and it is believed to support the critical function of thermoregulation in early postnatal life.
Therefore, Brown adipose tissue may also influence the development of neonatal energy balance.
Similar to white adipose tissue, it is hypothesized that development of Brown adipose tissue in utero is also influenced by maternal factors such as prepregnancy body mass index and gestational weight gain.
The research aims of this study to 1) identify maternal and neonatal factors that contribute to neonatal Brown adipose tissue and 2) to identify changes in neonatal Brown adipose tissue and to energy expenditure in response to a mild cold exposure.
To achieve these aims, we will conduct a cross-sectional, observational study in up to 60 infants 0-3 weeks of age.
Using state-of-the-art methodology, we will assess brown adipose tissue, body composition, and resting metabolic rate under thermoneutral and mild-cold stimulated conditions.
Study Type
Observational
Enrollment (Estimated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emily W Flanagan, PhD
- Phone Number: 225-763-2828
- Email: emily.flanagan@pbrc.edu
Study Contact Backup
- Name: Abby D Altazan, MS
- Phone Number: 225-763-2801
- Email: abby.duhe@pbrc.edu
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Recruiting
- Pennington Biomedical Research Center
-
Contact:
- Emily W Flanagan, PhD
- Phone Number: 225-763-2828
- Email: emily.flanagan@pbrc.edu
-
Contact:
- Abby D Altazan, MS
- Phone Number: 225-763-2801
- Email: abby.duhe@pbrc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 month (Child)
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
This study will enroll neonates from two mechanisms: 1) recruited from the greater Baton Rouge area, and 2) recruited from an ongoing prenatal weight maintenance intervention randomized controlled trial (R01DK099175).
Description
Inclusion Criteria:
- aged 0 weeks to less than 3 weeks at visit 1
- be willing to complete MRI procedures
Exclusion Criteria:
- Unable to complete two clinic visits within 14 days
- Born with health conditions that would render the procedures unsafe
- Born earlier than 36 and 0 days gestation
- Taken a steroid drug since birth
- Implanted metal or electronic objects that render MRI unsafe
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brown Adipose Tissue Fat-signal Fraction Difference Between Thermoneutral and Mild-Cold Environment
Time Frame: 14 days
|
The difference in the infants' fat-signal fraction (ratio of lipid to water, expressed as a percentage), assessed by Magnetic Resonance Imaging, between a thermoneutral environment and a mild-cold exposure.
|
14 days
|
Energy Expenditure Difference Between Thermoneutral and Mild-Cold Environment
Time Frame: 14 days
|
The difference in the infants' energy expenditure (expressed as kilocalories per day), assessed by room calorimetry, between a thermoneutral environment and a mild-cold exposure.
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brown Adipose Tissue Volume Difference Between Mothers Enrolled in Prenatal Intervention
Time Frame: 1 day
|
In an ancillary aim of the study, we will examine the difference in the infants' brown adipose tissue volume (expressed as cubic centimeters), assessed by Magnetic Resonance Imaging, between infants born to mothers enrolled in a prenatal weight maintenance intervention (R01DK124806) and infants born to mothers seeking routine prenatal care.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Emily W Flanagan, PhD, Pennington Biomedical Research Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 17, 2022
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
August 24, 2022
First Submitted That Met QC Criteria
August 24, 2022
First Posted (Actual)
August 26, 2022
Study Record Updates
Last Update Posted (Actual)
September 28, 2023
Last Update Submitted That Met QC Criteria
September 25, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PBRC 2021-054
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brown Adipose Tissue
-
Clinical Nutrition Research Centre, SingaporeInstitute of Bioengineering and Bioimaging (IBB)Active, not recruiting
-
Yale UniversityNYU Langone HealthCompletedBrown Adipose TissueUnited States
-
National Institute of Diabetes and Digestive and...RecruitingMolecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in MetabolismBrown Adipose Tissue (BAT) Physiology | Phenotyping | Brown AdipocytesUnited States
-
Pennington Biomedical Research CenterCompletedBody Composition | Brown Adipose TissueUnited States
-
Maastricht UniversityCompletedDiet-induced Thermogenesis | Brown Adipose Tissue ActivationNetherlands
-
Beth Israel Deaconess Medical CenterJoslin Diabetes Center; Chan Zuckerberg InitiativeRecruitingObesity | Adipose Tissue | Adipose Tissue, BrownUnited States
-
University Hospital, Basel, SwitzerlandRecruitingBrown Adipose TissueSwitzerland
-
Pennington Biomedical Research CenterCompletedBrown Adipose Tissue | ThermogenesisUnited States
-
University Hospital, Basel, SwitzerlandCompletedBrown Adipose TissueSwitzerland